SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Krebs Biochemicals & Industries informs about re-lodgement of transfer requests of physical shares

18 Nov 2025 Evaluate

In terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/97 dated 2nd July 2025, Krebs Biochemicals & Industries has informed that it enclosed report dated November 17, 2025 received from the Registrar and Share Transfer Agent of the Company, KFIN Technologies on re-lodgement of transfer requests of physical shares as on October 31, 2025. Further, the Notice to shareholders with respect to special window open for re-lodgement of transfer request of physical shares for a period of six months from July 7, 2025 till January 6, 2026 is available at the website of the Company at www.krebsbiochem.com.

The above information is a part of company’s filings submitted to BSE.

Krebs Biochem.&Inds Share Price

60.00 -2.15 (-3.46%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×